Bids Are Invited For Contracting For The Installment Supply Of, A, Anticoagulant Medications, Vitamins, Ophthalmics, Analgesics, Intestinal Tract And Hormones, Regular Human Insulin, Subcutaneous Heparin, Pulmonary Surfactant, Sodium Glycerophosphate Among Others,, B, Compounded Medications, Nimodipine And Verapamil, And C, Topical Antiseptic Solutions, For The University Hospital, Hu-Uel, And Hospital Veterinarian, Hv-Uel, From The State University Of Londrina, For A Period Of 12, Twelve Months.

(L1) 6501.1224-Atropine, Sulfate, 10 Mg/Ml (1%), Ophthalmic Solution, Drip Bottle, 5 Ml, Route Of Administration: Ophthalmic, Units. Size: Unit, (L1) 6501.1003-Timolol, Maleate, 5 Mg/Ml (0.5%), (L1) 6501.49543-Dexamethasone, 1Mg/Ml, Ophthalmic Suspension, Bottle, 5Ml, (L1) 6501.935-Pilocarpine, Hydrochloride, 20 Mg/Ml (2%), 10 Ml, (L1) 6501.31743-Moxifloxacin, Hydrochloride, 5 Mg/Ml, (L1) 6501.1004-Tobramycin + Dexamethasone, 3 Mg + 1 Mg/G, Ophthalmic Ointment, Tube, 3.5 G, (L2) 6501.229-Folinic Acid (Calcium Folinate), 15 Mg, Tablet, Blister, Route Of Administration: Oral, (L3) 6501.98941-Alteplase, 10Mg, Lyophilized Powder For Injection Solution, Ampoule Vial, Diluent, 10Ml, Route Of Administration: Intravenous, (L4) 6501.259-Aminophylline, 24 Mg/Ml, Injectable Solution, Ampoule, (L5) 6501.58228-Sodium Bicarbonate, Sodium Carbonate, Citric Acid, 2, 0, 5G, 2 G/5G, Oral Powder, Envelope, (L6) 6505.109191-Charcoal Activated, Oral, Powder, Powder, Primary Packaging: Sachet With 5 G., (L7) 6501.50119-Anhydrous Caffeine, 10Mg/Ml, Oral Solution, Packaging: Bottle, With 30Ml, (L8) 6501.520-Potassium Chloride, 60 Mg/Ml (6%), Oral Solution, 150 Ml, Dosing Cup/Syringe, (L9) 6501.48662-Cholecalciferol, 14,000Ui/Ml, (L10) 6502.5404-Tetracaine, Hydrochloride + Phenylephrine, 10 Mg/Ml (1%) + 1 Mg/Ml (0.1%), Ordinance 344/98: C1, (L11) 6501.48665-Desloratadine, Syrup, 100 Ml, (L12) 6501.37-Dipyrone Sodium, 500 Mg, (L13) 6501.4718-Erythromycin, Estolate, 50Mg/Ml, Oral Suspension, 50 Ml, % Accepted Variation (Up) In Primary Packaging Unit Of Measurement: 20, (L14) 6501.3756-Scopolamine, Butylbromide + Sodium Dipyrone, 6.7 Mg + 333.4 Mg/Ml, Drops Solution, 20Ml, (L15) 6501.1765-Scopolamine, Butylbromide, 20 Mg/Ml, 1 Ml, Route Of Administration: Subcutaneous/Intramuscular/Intravenous, (L16) 6501.3120-Fenoterol, Hydrobromide, 20 Ml, Route Of Administration: Oral/Inhalation, (L17) 6501.75320-Potassium Phosphate, 2 Meq/Ml, (L18) 6501.58460-Sodium Glycerophosphate, 216 Mg/Ml, (L19) 6501.1352-Sodium Heparin, 20,000 Iu/Ml (5,000 Iu/0.25Ml), 25 Ml, Route Of Administration: Subcutaneous, (L20) 6501.60729-Hydrocortisone, Acetate, 10 Mg/G, Dermatological Cream, 15 To 20 G, Route Of Administration: Dermatological, (L21) 6501.4756-Aluminum Hydroxide, 60 To 62 Mg/Ml, 100 To 150 Ml, (L22) 6501.795-Ibuprofen, 50 Mg/Ml, Suspension Drops, 30 Ml, (L23) 6501.3158-Nph Human Insulin, 100 Iu/Ml, Injectable Suspension, (L24) 6501.3160-Regular Human Insulin, (L25) 6501.838-Methylprednisolone, Sodium Succinate, 125 Mg, Powder For Injectable Solution, 2 Ml, Route Of Administration: Intramuscular/Intravenous, (L26) 6501.839-Methylprednisolone, 8 Ml, (L27) 6501.43094-Thiamazole, 10 Mg, (L28) 6505.97288-Neomycin, 250 Mg, Capsule, (L29) 6501.2506-Nimodipine, 30 Mg, Coated Tablet, (L30) 6501.1354-Octreotide, 1 Mg/Ml, Route Of Administration: Subcutaneous/Intravenous, (L31) 6501.1382-Oxymetazoline, 05%), Nasal Solution, Drip Bottle/Spray Bottle, Route Of Administration: Nasal, (L32) 6505.86610-Papain, 80 Mg/G (8%), Gel, Tube/Pot 60 G, Manipulated Product, Route Of Administration: Topical, (L33) 6505.76279-Papain, 100 Mg/G (10%), 20 G, (L34) 6505.86611-Papain, 60 Mg/G (6%), (L35) 6501.1398-Calcium Polystyrenesulfonate, 890/900 Mg/G, 30 G, (L36) 6501.2521-Polymyxin B, Sulfate + Neomycin, Sulfate + Hydrocortisone, 10,000 Iu + 5 Mg + 10 Mg/Ml, Otologic Suspension, Route Of Administration: Otologic, (L37) 6501.70303-Saccharomyces Boulardii, 200Mg, 1G, (L38) 6501.68460-Sacubitril Valsartan Sodium Hydrated, 50 Mg (